Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan

類似資料

• Correction to: Safety and effectiveness of long-term use of darbepoetin alfa in non-dialysis patients with chronic kidney disease: a post-marketing surveillance study in Japan
  著者:: Tanaka, Tetsuhiro, 等
  出版事項: (2019)
• Initial responsiveness to darbepoetin alfa and its contributing factors in non-dialysis chronic kidney disease patients in Japan
  著者:: Hayashi, Terumasa, 等
  出版事項: (2020)
• Darbepoetin Alfa in Patients with Advanced CKD without Diabetes: Randomized, Controlled Trial
  著者:: Hayashi, Terumasa, 等
  出版事項: (2020)
• Population pharmacokinetics of darbepoetin alfa in haemodialysis and peritoneal dialysis patients after intravenous administration
  著者:: Takama, Hirotaka, 等
  出版事項: (2007)
• Rationale and design of oBservational clinical Research In chronic kidney disease patients with renal anemia: renal proGnosis in patients with Hyporesponsive anemia To Erythropoiesis-stimulating agents, darbepoetiN alfa (BRIGHTEN Trial)
  著者:: Kato, Hideki, 等
  出版事項: (2017)